22. May 2023 Pipeline Phase 2 data with NicaPlant ® in aneurysmal subarachnoid haemorrhage patients will be presented at the XXVI Congress of Spanish Society of Neurosurgery (SENEC)
14. December 2022 Company Augxano and BIT Pharma enter into an Agreement for Commercialization Support in Asia
29. October 2022 Company ASPEN And BIT PHARMA Enter Into An Exclusive Agreement For A Nicardipine-Based Intracerebral Implant
19. October 2022 Pipeline European Medicines Agency Grants PRIME Designation to BIT Pharma’s NicaPlant® for Treatment of Non-traumatic Subarachnoid Haemorrhage in Patients undergoing Surgery.
31. August 2022 Pipeline BIT Pharma Announces the Presentation of NicaPlant® Phase 2 Results at International Conferences
1. July 2022 Pipeline BIT Pharma Announces Positive Phase 2b Study Results for NicaPlant® in Aneurysmal Subarachnoid Heamorrhage patients (aSAH) undergoing aneurysm clipping.
